Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAYLEE D WHITE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1427661289
CMS profile
11232549
Location
ALBANY, GA

General Payments · PY2021–2024

$485.92

  • Reported across 25 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$297.88

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $297.88 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $107.16 5
Novo Nordisk AS $71.94 4
Lilly USA, LLC $48.12 3
Amgen Inc. $31.37 2
Vanda Pharmaceuticals Inc. $20.93 1
Astellas Pharma US Inc $18.36 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $28.39 2
PY2022 $126.93 5
PY2023 $32.72 2
PY2024 $297.88 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $13.64 02/15/2024 Food and Beverage Undisputed 01/23/2026 1117716890 CMS
Amgen Inc. $17.73 06/13/2024 Food and Beverage Undisputed 01/23/2026 1117716892 CMS
Astellas Pharma US Inc $18.36 05/02/2024 Food and Beverage Undisputed 01/23/2026 1139500698 CMS
AstraZeneca Pharmaceuticals LP $15.68 02/08/2024 Food and Beverage Undisputed 01/23/2026 1104254981 CMS
AstraZeneca Pharmaceuticals LP $23.63 05/23/2024 Food and Beverage Undisputed 01/23/2026 1105681627 CMS
AstraZeneca Pharmaceuticals LP $15.26 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105548617 CMS
AstraZeneca Pharmaceuticals LP $28.77 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105482419 CMS
AstraZeneca Pharmaceuticals LP $23.82 09/05/2024 Food and Beverage Undisputed 01/23/2026 1105469989 CMS
Lilly USA, LLC $17.66 02/29/2024 Food and Beverage Undisputed 01/23/2026 1135771110 CMS
Lilly USA, LLC $15.63 03/08/2024 Food and Beverage Undisputed 01/23/2026 1135759598 CMS
Lilly USA, LLC $14.83 04/09/2024 Food and Beverage Undisputed 01/23/2026 1135771108 CMS
Novo Nordisk Inc $16.70 02/01/2024 Food and Beverage Undisputed 01/23/2026 1100408725 CMS
Novo Nordisk Inc $21.33 02/22/2024 Food and Beverage Undisputed 01/23/2026 1100259787 CMS
Novo Nordisk Inc $17.71 04/25/2024 Food and Beverage Undisputed 01/23/2026 1100569362 CMS
Novo Nordisk Inc $16.20 06/27/2024 Food and Beverage Undisputed 01/23/2026 1100276032 CMS
Vanda Pharmaceuticals Inc. $20.93 08/22/2024 Food and Beverage Undisputed 01/23/2026 1133976324 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.